Cash Strategies for Life Sciences Delays
By

The one constant when raising financing in a life sciences company is that it takes longer than initially forecasted.  As previously shared in my colleague Patrick Nugent’s article about Life Sciences Financing Trends, it is taking twice as long to close a financing round (six months or more), and the length of time…Read More

Read More
A Quick Review of the LSI USA 2025 Conference
By

This month, FLG Partner and CFO Patrick Nugent attended the LSI USA 2025 Conference, “Emerging Medtech Summit,” in Dana Point, California. This annual event is well-represented not only by Medtech companies but also by investors and strategists, resulting in well over 1,500 attendees. “LSI proved Medtech innovations are alive and…Read More

Read More
Trends in Financing in Life Sciences: 2024 Updates
By

This article is first in a 4-part series reviewing financing solutions for the Life Science sector. As we move into Q2 of 2024, the Fed continues to hold the line on interest rate declines. Capital markets remain tight and for companies in need of growth financing, this is problematic. This…Read More

Read More